Skip to content Skip to main navigation
MENU

Dr. Zoe Moodie, Fred Hutchinson Cancer Centre

Title: Biostatistical contributions to infectious disease research and a look to the future

Date: Friday, November 20th, 2026
Time: 1:30PM (PDT)
Location: ASB 10900

Abstract:  In this talk, I will describe the study design considerations and statistical methods I have developed, applied, and taught over the past 25 years as a biostatistician working at the forefront of infectious disease research. I will focus on my HIV vaccine clinical trials research, from early phase trials through to efficacy trials, including my work on the HVTN 702 Phase 2b/3 efficacy trial in South Africa. The HVTN 702 vaccine regimen was designed to improve on the vaccine efficacy shown in an earlier trial in Thailand yet failed to demonstrate any efficacy, likely due to the higher HIV viral diversity and force of infection in South Africa compared to Thailand. I will conclude by describing current and future projects with the CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research, including HIV PrEP implementation studies in Canada.